News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ACCU-BREAK Pharmaceuticals, Inc. Announces Appointment Of Lawrence Rosenthal, Former President Of Andrx Pharmaceuticals, Inc.


11/30/2006 11:24:37 AM

PLANTATION, Fla.--(BUSINESS WIRE)--ACCU-BREAK Pharmaceuticals, Inc. (“ABP” or the “Company”), announced today that Lawrence Rosenthal has been named Vice President of the Company and President of its wholly-owned subsidiary, ACCU-BREAK Generics, Inc. Previously, Mr. Rosenthal served as President of Andrx Pharmaceuticals, Inc., a subsidiary of Andrx Corporation, which was recently acquired by Watson Pharmaceuticals, Inc. (NYSE:WPI). Mr. Rosenthal has also been Vice President, Sales and Marketing of Teva Pharmaceuticals, Inc. USA (NASDAQ:TEVA). He is a long standing member of the Board of Directors of the Generic Pharmaceutical Association.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES